- 现金
- 3700 元
- 精华
- 16
- 帖子
- 1790
- 注册时间
- 2002-12-9
- 最后登录
- 2021-4-14
|
2楼
发表于 2004-7-21 23:37
Other References
Robins, "Selective Deoxygenation and Modification at C2' of Nucleosides," pp. 1-4 in Nucleic Acids Research Symposium Series, vol. No. 11, Kyoto, Japan, Nov. 24-26, 1982, A. E. Pritchard (ed.), IRL Press, Ltd., Oxford, England, 1982; see also Chemical Abstracts, 98, Abstract No. 107670u (1982).*
Verri et al., "Relaxed Enantioselectively of Human Mitochondrial Thymidine Kinase and Chemotherapeutic Uses of L-Nucleoside Analogues," Biochemical Journal, 328(1), 317-320 (Nov. 15, 1997).*
Lin et al., "Design and Synthesis of 2', 3'-Deoxy-2', 3'-didehydro-.beta.-L-cytidine (.beta.-L-d4C) and 2', 3'-Dideoxy-2', 3'-didehydro-.beta.-L-5-fluorocytidine (.beta.-L-Fd4C), Two Exceptionally Potent Inhibitors of Human Hepatitis B Virus (HBV) and Potent Inhibitors of Human Immunodeficiency Virus (HIV) In Vitro," Journal of Medicinal Chemistry, 39(9), 1757-1759 (Apr. 26, 1996).*
von Janta-Lipinski et al., "Newly Synthesized L-Enantiomers of 3'-Fluoro-Modified .beta.-2'-Deoxyribonucleoside 5'-Triphosphates Inhibit Hepatitis B DNA Polymerase But Not the Five Cellular DNA Polymerase .alpha., .beta., .gamma., .delta., and .epsilon. Nor HIV-1 Reverse Transcriptase," Journal of Medicinal Chemistry, 41(12), 2040-2046 (Jun. 4, 1996).*
Mansour et al., "Stereochemical Aspects of the Anti-HCMV Activity of Cytidine Nucleoside Analogues," Antiviral Chemistry & Chemotherapy, 6(3), 138-142 (1995).*
Spadari et al., "L-Thymidine Is Phosphorylated by Herpes Simplex Type 1 Thymidine Kinase and Inhibits Viral Growth," Journal of Medicinal Chemistry, 35(22), 4214-4220 (1992).*
Bryant et al., "Antiviral L-Nucleosides Specific for Hepatitis B Virus Infection," Antimicrobial Agents and Chemotherapy, 45(1), 229-235 (Jan., 2001).*
Wang et al., "Recovery of Liver Sinusoidal Endothelial Cell Function over Time After Hypothermic Preservation in Rat Orthotopic Liver Transplantation," AASLD Abstracts published in Hepatology, 24(No. 4, Pt. 2), p. 431A, Abstract No. 1219 (1996).*
Arner and Erikksson, "Mammalian Deoxyribonicleoside Kinases," Pharm. Ther., 1995, 67(2), 155-186.
Berk et al., "A Genetically Distinct Tymidine Kinase in Mammalian Mitochondria," J Biol Chem, 1973, 248, 2722-2729. (Issue No. 8, Apr. 25, 1973).
Bestwick et al., "Selective Expansion of Mitochondrial Nucleoside Triphosphate Pools in Antimetabolite-treated HeLa Cells," J Biol Chem, 1982, 257, 9300-9304.(No. 6; Aug. 25, 1982).
Bridges et al., "Characterization of a dCTP Transport Activity Reconstituted from Human Mitochondria," J. Biol. Chem, Feb. 19, 1999, 274(8), 4620-4625.
Bridges et al., "Identification of a novel mitochondrial dNTP carrier and its interaction with anti-HIV nucleoside analogs," Proc. Am. Assoc. Cancer Res., Mar. 1997, 38, Abstr. No. 414, p. 62.
Bridges et al., "Inhibition of Mammalian DNA Polymerase-Associated 3' to 5' Exonuclease Activity by 5'-Monophosphates of 3'-Azido-3'-Deoxythymine and 3'-Amino-3'-Deoxythymidine," Biochemical Pharmacology, 1993, 45(8), 1571-1576.
Chariot et al., "Zidovudine-induced mitochondrial disorder with massive liver steatosis myopathy, lactic acidosis, and mitochondrial DNA depletion," J. Hepatology, 1999, 30, 156-160
Chang et al., "Biochemical Pharmacology of (+)- and (-)-2',3'-Dideoxy-3'-thiacytidine as Anti-hepatitis B Virus Agents," J Biol Chem, Nov. 5, 1992, 267(31), 22414-22420.
Chen et al., "Characterization of Pyrimidine Deoxyribonucleoside Kinase (Thymidine Kinase) and Thymidylate Kinase as a Multifunctional Enzyme in Cells Transformed by Herpes Simplex Virus Type 1 and in Cells Infected with Mutant Strains of Herpes Simplex Virus," J Virol, Jun. 1979, 30, 942-945.
Chen et al., "Delayed Cytotoxicity and Selective Loss of Mitochondrial DNA in Cells Treated with the Anti-human Immunodeficiency Virus Compound 2',3'-Dideoxycytidine," J Biol Chem, 1989, 264, 11934-11937. (Issue No. 20; Jul. 15, 1989).
Chen et al., "The Role of Cytoplasmic Deoxycytidine Kinase in the Mitochondrial Effects of the Anti-human Immunodeficiency Virus Compound 2',3'-Dideoxycytine," J Biol Chem, Feb. 15, 1992, 267(5), 2856-2859.
Cui et al., "Effect of Nucleoside Analogs on Neurite Regeneration and Mitochondrial DNA Synthesis in PC-12 Cells," J. of Pharmacology and Experimental Therapeutics, 1997, 280(3), 1228-1234.
Davis et al., "In Situ Localization of Mitochondrial DNA Replication in Intact Mammalian Cells," J Cell Biol, 1996, 135, 883-893. (Issue No. 4; Nov., 1996).
Doong et al., "Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues," Proc. Natl. Acad. Sci., Oct. 1991, 88, 8495-8499.
Dutschman et al., "Metabolism of 2',3'-dideoxy-2',3'-didehydro-.beta.-L-(-)-5-Fluorocytidine and Its Activity in Combination with Climically Approved Anti-Humna Immunodeficiency Virus .beta.-D-(+) Nucleoside Analogs In Vitro," Antimicrobial Agents and Chemotherapy, Jul. 1998, 42(7), 1799-1804.
Hernandez-Santiago et al., "harmacology of .beta.-L-Thymidine and .beta.-L-2'-Deoxycytidine in HepG2 Cell and Primary Human Hepatocytes: Relevance to Chemotherapeutic Efficacy against Hepatitis B Virus," Antimicrobial Agents and Chemotherapy, Jun. 2002, 46(6), 1728-1733.
Jurovcik and Holy "Metabolism of pyrimdine L-nucleosides," Nucleic Acids Research, Aug. 1976, 3(8), 2143-2153.
Krayevsky and Chernov, "Can a Substrate Enantiomer Be a Substrate for the Same Enzyme?," Molecular Biology, 1996, 30(5), 585-591.
Krayevsky and Chernov, "Should the Asymmetric of Enzymatic Active Centers Always Correlate with the Asymmetry of their Substrates?," J. of Bionolecular Structure & Dynamics, 1996, 14(2), 225-230.
Labenz et al., "Analysis of the TK Enzyme Complex Induced by HSV Types 1 and 2 by Means of Isoelectric Focusing and Polyacyrlamide Gel Electrophoresis," Arch Virol, 1982, 71, 235-249.
Lin et al., "Synthesis and Biological Evaluation of 2',3'-Dideoxy-L-pyrimidine Nucleosides as Potential Antiviral Agents agains HIV and HBV," J. Med. Chem, 1994, 97, 798-803. (Issue No. 6).
Pan-Zhou et al., "Differential Effects of Antiretroviral Nucleoside Analogs on Mitochondrial Function in HepG2 Cells," Antimicrobial Agents and Chemotherapy, Mar. 2000, 44(3), 496-503.
Placidi et al., "Cellular pharmacology of .beta.-L-thymidine and .beta.-L-2'-deoxycytidine in HepG2 cells and primary rat, monkey and human hepatocytes," 3.sup.rd Int. Conf. Ther. Vir. Hepatitis, abstr. A122, 1999 [Antivir. Ther. 4, Suppl. 4]. (Dec. 12-16, 1999).
Soderlund and Arner, "Mitochondrial versus Cytosololic Activities of Deoxyribonucleoside Salvage Enzymes," Purine and Pyrimidine Metabolism in Man VIII, A.Shota & M. Taylor (ed.), Plenum Press, New York, 1995, 201-204.
Zhu et al., "Anti-Hepatitis B Virus Activity and Metabolism of 2',3'-dideoxy-2',3'-didehydro-.beta.-L-(-)-5-Fluorocytidine," Antimicrobial Agents and Chemotherapy, Jul. 1998, 42(7), 1805-1810.
Zhu et al., "Incorporation of Nucleoside Analogs into Nuclear or Mitochondrial DNA Is Determined by the Intracellular Phosphorylation Site," J Biol Chem, 2000, 275(35), 26727-26731 (Sep. 1, 2000).
Zhu et al., "Inhibition of Replication of Hepatitis B Virus by Cytallene In Vitro," Antimicrobial Agents and Chemotherapy, Aug. 1997, 41(8), 1755-1760.
Bloch, et al. "The Role Of The 5'-Hydroxyl Group Of Adenosine In Determining Substrate Specificity For Adenosine Deaminase." J. Med. Chem. 10(5), 908-12 (Sep. 1967).
Chang, et al., "Deoxycytidine Deaminase-resistant Stereoisomer is the Active Form of (-)-2',3'-thiacytidine in the Inhibition of Hepatitis B Virus Replication," Journal of Biological Chemistry, vol. 267(20), 13938-13942 (Jul. 15, 1992).
Davisson, et al., "Synthesis of Nucleotide 5'-Diphosphates from 5'-O-Tosyl Nucleosides," J. Org. Chem., 52(9), 1794-1801 (1987).
Du et al, Synthesis, "Anti-Human Immunodeficiency Virus and Anti-Hepatitis B Virus Activities of Novel Oxaselenolane Nucleosides," J. of Med. Chem., (40)19, 2991-2993 (Sep. 12, 1997).
Furman, et al., "The Anti-Hepatitis B Virus Activities, Cytotoxicities, and Anabolic Profiles of the (-) and (+) Enantiomers of cis-5-Fluoro-1-[2-(Hydroxymethyl)-1,3-oxathiolane-5-yl]-Cytosine" Antimicrobial Agents and Chemotherapy, 36(12) 2686-1692 (Dec. 1992).
Gosselin, G. et al. "Synthesis and Antiviral Evaluation of .beta.-L-Xylofuranosyl Nucleosides of the Five Naturally Occuring Nucleic Acid Bases", Journal of Heterocyclic Chemistry, 1993, 30 (Oct.-Nov.), 1229-1233.
Hoard, et al., "Conversion of Mono- and Oligodeoxyribonucleotides to 5'-Triphosphates," J. Am. Chem. Soc., 87(8), 1785-1788 (1965).
Holy. "Nucleic Acid Components and Their Analogs. CLIII. Preparation of 2'-deoxy-L-Ribonucleosides of the Pyrimidine Series," Collect. Czech. Chem. Commun. (1972), 37(12),4072-87.
Hostetler, K.Y., et al. "Greatly Enhanced Inhibition Of Human Immunodeficiency Virus Type 1 Replication In CEM And HT4-6C Cells By 3'-Deoxythymidine Diphosphate Dimyristoylglycerol, A Lipid Prodrug Of 3'-Deoxythymidine." (Sep. 1992) Antimicrob Agents Chemother. 36:2025-2029.
Hostetler, K.Y., et al. "Synthesis And Antiretroviral Activity Of Phospholipid Analogs Of Azidothymidine And Other Antiviral Nucleosides." (Apr. 15, 1990) J. Biol Chem. 265(11):6112-7.
Imai et al., "Studies on Phosphorylation. IV. Selective Phosphorylation of the Primary Hydroxyl Group in Nucleosides." J. Org. Chem., 34(6), 1547-1550 (Jun. 1969).
Jones,R. et al., "Mini Review: Nucleotide prodrugs," Antiviral Research, 27, 1-17 (1995).
Korba et al., "A cell culture assay for compounds which inhibit hepatitis B virus replication," Antiviral Res., 15:217 (1991).
Kucera, L.S., et al., "Novel membrane-interactive ether lipid analogs that inhibit infectious HIV-1 production and induce defective virus formation." AIDS Res Hum Retroviruses. 6:491-501 (May 1990).
Lin et al., "Synthesis of Several Pyrimidine L-Nucleoside Analogues as Potential Antiviral Agents," Tetrahedron:, vol. 51(4), 1055,1068 (1995).
Maga et al., "Lack of stereospecifity of suid pseudorabies virus thymidine kinase," Biochem. J. , 294(2), 381-385 (Sep. 1, 1993).
Nakayama, C., et al., "Synthetic Nucleosides and Nucleotides. XX. Synthesis of Various 1-.beta.-Xylofuranosyl-5-Alkyluracils and Related Nucleosides." Nucleosides, Nucleotides, 1, 139-146 (1982).
Norbeck, Tetrahedron Letters, 30 (46), 6246 (1989).
Robins, M. J. et al. "urine nucleosides. XXIX. The synthesis of 2'-deoxy-L-adenosine and 2'-deoxy-L-guanosine and their alpha anomers." J. Org. Chem. Mar. 1970, 35, 636-639.
Robins, M.J., et al., "Nucleic Acid Related Compounds. 42. A General Procedure for the Efficient Deoxygenation of Secondary Alcohols. Regiospecific and Stereoselective Conversion of Ribonucleosides to 2'-Deoxynucleosides." J. Am. Chem. Soc. 105, 4059-4065 (1983). (Jun. 15, 1983).
Saneyoshi, M., et al., "Synthetic Nucleosides and Nucleotides. XIII. Stannic Chloride Catalyzed Ribosylation of Several 6-Substituted Purines." Chem. Pharm. Bull., 27, 2518-2521 (1979).
Schinazi, et al., "Selective Inhibition of Human Immunodeficiency Viruses by Racemates and Enantiomers of cis-5-Fluoro-1-[2-(Hydroxymethyl)-1,3-Oxathiolane-5-yl] Cytosine," Antimicrobial Agents and Chemotherapy, 36(11), 2423-2431 (1992). (Nov., 1992).
Schinazi, et al., "Effect of Combinations of Acylovir with Vidarabine or its `Monophosphate` on Herpes Simplex Viruses in Cell Culture and in Mice," Antimicrobial Agents and Chemotherapy, 22(3), 499, (1982). (Jul., 1982).
Shuto, S., et al. "A facile one-step synthesis of 5'-phosphatidylnucleosides by an enzymatic two-phase reaction." Tetrahedron Letters. 28. 199-202 (1987).
Tyrsted et al. "Inhibition of the synthesis of 5-phosphoribosyl-1-pyrophosphate by 3'-deoxy-adenosine and structurally related nucleoside analogs." Biochim. Biophys. Acta. (Feb. 26, 1968), 155(2), 619-22.
Verri et al. "Lack of enantiospecificity of human 2'-deoxycytidine kinase: relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agents." Molecular Pharmacology. (Jan. 1997), 51(1), 132-138.
Zedeck et al. "seudomonas testosteroni," Mol. Phys. (1967), 3(4), 386-95.
Zhang, W., et al. "Removal of Silyl Protecting Groups from Hydroxyl Functions with Ammonium Fluoride in Methanol." Tetrahedron Letter., 33, 1177-1180 (192).
Primary Examiner: Richter; Johann
Assistant Examiner: Crane; L Eric
Attorney, Agent or Firm: King & Spalding L.L.P., Knowles; Sherry M.
|
|